METTL1通过ATF4mRNA的m7G修饰协调皮肤状细胞癌的进展
Xinru Zhang1, Tong Chen1, Fanrong Zhang1
1School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, China.
Cell death discovery
|January 27, 2025
概括
甲基转移酶类型1 (METTL1) 通过修改ATF4mRNA来推动皮肤状细胞癌 (cSCC). 抑制METTL1抑制了cSCC的生长,突出显示METTL1是这种癌症的潜在治疗标.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 由甲基转移酶样1 (METTL1) 催化的N7-甲基瓜诺辛 (m7G) 修饰在RNA中普遍存在,并与各种癌症有关.
- 在皮肤状细胞癌 (cSCC) 中,METTL1-介导的m7G修饰的特定作用仍然在很大程度上未被阐明.
研究的目的:
- 研究METTL1-介导的m7G修饰在皮肤状细胞癌 (cSCC) 的发展中的作用和机制.
- 探索METTL1作为cSCC的潜在治疗点.
主要方法:
- 在cSCC瘤和细胞系中量化METTL1水平.
- 在METTL1抑制后评估cSCC细胞行为 (生存,迁移,入侵) 和异种移植瘤生长.
- RNA测序,m7G特异性免疫沉 (MeRIP) -qPCR和mRNA稳定性测试用于识别METTL1的点和机制.
- 在cSCC瘤中分析METTL1和ATF4表达之间的关联.
- 评估ATF4在cSCC糖解中的作用和对METTL1抑制的反应.
主要成果:
- 在cSCC瘤和细胞系中,METTL1水平显著升高.
- 抑制METTL1降低了cSCC细胞的存活率,迁移,入侵和异种移植瘤的生长.
- 具体而言,METTL1是m7G修饰的ATF4mRNA,通过增加稳定性来增强其表达.
- METTL1的甲基转移酶活性对于ATF4mRNA修饰至关重要.
- 在cSCC中,ATF4表达与METTL1水平正相关.
- 在cSCC细胞中恢复ATF4表达促进了葡萄糖分解,并抵消了METTL1的抗瘤作用.
结论:
- METTL1及其m7G修饰在促进cSCC瘤发生方面发挥着关键作用,部分是通过ATF4.4的上调调节.
- METTL1-ATF4轴代表了皮肤状细胞癌的一个有前途的治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)